Skip to main content
Equibles
OHI logo

OHI · Omega Healthcare Investors Inc · Metrics

Track OHI — free

Use OHI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OHI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$45.55 +0.66 (+1.47%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$13.60B
Shares
303.01M
Volume · Oct 20 1.61M Avg daily vol (3M) 1.92M

OHI metrics

96 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$44.89
Market cap
$13.60B

Price action

20 metrics
Price change (1W)
-0.6%
Price change (30D)
-4.1%
Price change (3M)
-9.5%
Price change (6M)
-3.5%
Price change (YTD)
+1.2%
Price change (1Y)
+9.3%
Trailing year
Price change (5Y)
+42.7%
52-week high
$51.72
52-week low
$39.53
Change from 52-week high
-13.2%
Change from 52-week low
+13.6%
Annualized volatility
21.2%
Annualized volatility (3M)
18.5%
Beta
-0.3
RSI (14D)
42.3
Price vs SMA 50
-2.9%
Price vs SMA 200
-3.5%
Avg volume (3M)
1.92M
Relative volume
0.7
Average dollar volume
$90.53M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
303.01M

Valuation

14 metrics
P / FFO
—
P / AFFO
15.2×
Company-stated · TTM · reciprocal yield 6.6%
P / E (TTM)
16.0
Trailing earnings · reciprocal yield 6.3%
PEG ratio
0.1
EV / revenue
14.1×
reciprocal yield 7.1%
EV / EBITDA
26.8×
reciprocal yield 3.7%
EV / EBIT
49.8×
reciprocal yield 2.0%
P / sales
10.8×
reciprocal yield 9.3%
P / book
2.6
reciprocal yield 39.0%
FCF yield
—
TTM · current market cap
Buyback yield
1.0%
P / FCF
—
P / operating cash flow
15.5
reciprocal yield 6.4%
Earnings yield
6.2%

Historical valuation

8 metrics
P / E historical average (3Y)
26.1×
reciprocal yield 3.8%
P / E historical average (5Y)
23.8×
reciprocal yield 4.2%
EV / revenue historical average (3Y)
14.3×
reciprocal yield 7.0%
EV / revenue historical average (5Y)
13.7×
reciprocal yield 7.3%
EV / EBIT historical average (3Y)
29.5×
reciprocal yield 3.4%
EV / EBIT historical average (5Y)
29.5×
reciprocal yield 3.4%
EV / EBITDA historical average (3Y)
15.0×
reciprocal yield 6.7%
EV / EBITDA historical average (5Y)
15.0×
reciprocal yield 6.7%

Dividends & buybacks

7 metrics
Dividend yield
6.0%
Trailing 12 months
Payout ratio
92.6%
Shareholder yield
—
Dividend / share (TTM)
$2.69
Dividend growth YoY
+0.4%
Dividend growth streak
0
Last ex-dividend
2026-08-03

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
67.0%
Gross profit (TTM)
—
Operating profit (TTM)
$380.67M
Net income (TTM)
$858.43M
Trailing 12 months
Diluted EPS (TTM)
$2.81
FCF margin
—
Effective tax rate
1.8%

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$4.09
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$2.74
Operating cash flow per diluted share (TTM)
$2.84
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.17
Book value per share
$17.53

Growth

11 metrics
Revenue growth YoY
+16.2%
Year over year
Net income growth YoY
+165.6%
Revenue (TTM)
$1.28B
Trailing 12 months
EPS growth YoY
+158.7%
Shares change YoY
+4.3%
Year over year · more shares
Revenue CAGR (3Y)
+10.7%
Revenue CAGR (5Y)
+5.9%
EPS CAGR (3Y)
+2.5%
EPS CAGR (5Y)
+22.6%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
15.9%
Return on assets
8.6%
Debt / equity
0.8
Current ratio
—
EBITDA (TTM)
$708.46M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
7.3
Return on invested capital
—
Trailing 12 months
Net cash
−$4.23B
Latest balance sheet
Cash & equivalents
$39.04M
Total assets
$10.01B
Total debt
$4.26B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$890.56M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$53.19M
R&D / revenue
—
Stock compensation / revenue
4.1%

Ownership (13F)

9 metrics
13F filers
768
13F filer change QoQ
+12
Institutional ownership
82.2%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
10.0%
Private-fund adviser ownership
9.4%
Active holders' share change QoQ
+3.8%
Holder tenure
14.6
Price vs estimated holder cost
+14.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.0%

Short interest

3 metrics
Short interest
5.2%
Latest settlement · 7.8 days to cover
Days to cover
7.8d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 888491 CUSIP 681936100 13F (30d) 117 filings 107 filers Visit website Investor relations